Does Credicorp (BAP) Upgraded Zacks Rank Reveal a Deeper Shift in Its Earnings Power?

Credicorp Ltd. -0.38%

Credicorp Ltd.

BAP

339.98

-0.38%

  • Zacks recently upgraded Credicorp to a Rank #1 (Strong Buy) after analysts raised their earnings estimates, signaling improved sentiment toward the group’s underlying business outlook.
  • This shift in analyst expectations highlights how Credicorp’s evolving earnings profile is increasingly central to how market participants assess its long‑term potential.
  • We’ll now examine how the Zacks Rank upgrade and stronger earnings forecasts could reshape Credicorp’s investment narrative and risk profile.

AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Credicorp Investment Narrative Recap

To own Credicorp, you need to be comfortable with a Peru focused financial group whose fortunes are tightly linked to local credit demand, regulation and digital adoption. The Zacks Rank upgrade reflects higher earnings estimates in the near term, but it does not remove the key short term catalyst of how sustainably Credicorp can grow retail and digital lending, nor does it materially lessen the risk that Peru’s political and regulatory backdrop could still unsettle earnings.

The recent update on the SUNAT tax dispute, where resolutions totaling about S/1.6 billion were canceled with no additional provisions booked, is especially relevant here. It directly addresses one of the largest overhangs for Credicorp’s risk profile and gives investors more clarity around potential capital strain, which in turn connects back to how much flexibility the group has to keep investing in growth platforms like Yape while maintaining resilience.

Yet this clearer tax picture still leaves investors exposed to Peru specific political and regulatory shocks that could...

Credicorp's narrative projects PEN27.2 billion revenue and PEN8.1 billion earnings by 2028. This requires 11.0% yearly revenue growth and about PEN1.8 billion earnings increase from PEN6.3 billion today.

Uncover how Credicorp's forecasts yield a $300.99 fair value, in line with its current price.

Exploring Other Perspectives

BAP 1-Year Stock Price Chart
BAP 1-Year Stock Price Chart

Four members of the Simply Wall St Community currently see Credicorp’s fair value anywhere between US$213.23 and US$492.83, underscoring how far opinions can diverge. When you weigh those views against Credicorp’s concentrated Peru exposure and evolving digital lending risk, it becomes even more important to compare several perspectives before deciding how its earnings profile might hold up.

Explore 4 other fair value estimates on Credicorp - why the stock might be worth as much as 63% more than the current price!

Build Your Own Credicorp Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Credicorp research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Credicorp research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Credicorp's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • Find companies with promising cash flow potential yet trading below their fair value.
  • The latest GPUs need a type of rare earth metal called Dysprosium and there are only 39 companies in the world exploring or producing it. Find the list for free.
  • Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.